Funding will extend the Nerve Tape product line and accelerate clinical adoption.

In cadaveric nerve repairs, Nerve Tape reduced surgical time while achieving increased repair quality & strength.

Nerve Tape receives FDA 510(k) clearance, becomes first sutureless nerve repair device.

The Georgia Research Alliance celebrates BioCircuit's Small Business Innovation Research award.

Bioelectronics ‘jump-start’ the next wave of device therapeutics.

Monitoring, controlling, and repairing peripheral nerves to improve patient health.

This study suggests that Nerve Tape can be reliably localized on MRI and ultrasound.

Funding will carry the Nerve Tape® nerve repair device through commercial launch.

Partnership announced with porcine-derived bioproduct supplier to deliver innovative nerve repair solution.

BioCircuit receives $4.6M grant to develop a non-invasive system to treat spinal cord injury.

10 Years Later: Georgia venture capital fund paying off for state, startup.

Surgeons across the US are now using Nerve Tape to achieve sutureless nerve repair.

Funds from this round will be used to commercialize Nerve Tape® and support future research.

BioCircuit's nerve repair device featured as the cover article of VCU's Annual research report.

OnBoard announces Michelle Jarrard as the recipient of its 17th annual Lettie Pate Whitehead Evans Award.

New Purdue AI tech to track treatment of chronic stomach disease.